Evidence map›Paper›PMID 35422861›Full record

ArticleJournal of oncology2022

A Novel Four Genes of Prognostic Signature for Uveal Melanoma.

Yan Liu, Huibin Du, Qi Wan, Yan He, Wei Lu, Wenhao Wang, Xiaohui Lv

Open access · hybridAbstract read
In one paragraph

Article in Journal of oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yan LiuDepartment of Ophthalmology, Affiliated Hospital of Weifang Medical University, Weifang City, Shandong Province, China.ORCID https://orcid.org/0000-0003-3238-0418
Huibin DuDepartment of Ophthalmology, People's Hospital of Leshan, Leshan City, Sichuan Province, China.ORCID https://orcid.org/0000-0002-4305-2332
Qi WanDepartment of Ophthalmology, People's Hospital of Leshan, Leshan City, Sichuan Province, China.
Yan HeDepartment of Ophthalmology, People's Hospital of Leshan, Leshan City, Sichuan Province, China.
Wei LuDepartment of Ophthalmology, People's Hospital of Leshan, Leshan City, Sichuan Province, China.
Wenhao WangDepartment of Medical Oncology, Affiliated Hospital of Weifang Medical University, Weifang City, Shandong Province, China.ORCID https://orcid.org/0000-0002-0067-8108
Xiaohui LvDepartment of Ophthalmology, Affiliated Hospital of Weifang Medical University, Weifang City, Shandong Province, China.ORCID https://orcid.org/0000-0002-5598-0646
People's Hospital of Bishan District · CNWeifang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autophagy and immunity play critical roles in various cancers, but the prognostic impact of autophagy and immunity for uveal melanoma (UM) remains lacking. Therefore, the RNA sequencing of data in the TCGA-UVM dataset was downloaded from UCSC Xena database. The prognostic autophagy- and immunity-related genes (AIRGs) were selected via univariate Cox regression. Next, we applied LASSO method to construct four genes of signature in the TCGA-UVM and verified in another two GEO datasets (GSE84976 and GSE22138). This signature intimately associated with overall survival (OS) time and metastasis-free survival (MFS) time of UM, which could be considered as a prognostic indicator. Besides, by applying risk assessment, the patients of UM can be divided into two subgroups (high/low risk) with different survival time, distinct clinical outcomes, and immune microenvironments. Gene set enrichment analysis (GSEA) manifested that cancer hallmark epithelial-mesenchymal transition and KRAS pathways were positively activated in the high-risk group. Moreover, the high-risk group could be more sensitive to chemotherapies than the low-risk group. Thus, our finding suggested that the four genes of signature closely linked with UM risk and survival can afford more accurate survival prediction and potential therapeutic targets for clinical application.

Identifiers

PMID35422861
PMCPMC9005314
OpenAlexW4226135565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.